Cholangitis and cholecystitis are two of the most common biliary tract diseases and are often confused for one another. Cholangitis is an inflammation of the bile ducts, while cholecystitis is an inflammation of the gallbladder. Both of these conditions can cause severe pain and other symptoms, so it is important for doctors to be able to distinguish between them. In this article, we will discuss the differences between cholangitis and cholecystitis, as well as the symptoms, causes, and treatments for each condition.
Cholangitis is an inflammation of the bile ducts. The bile ducts are responsible for carrying bile from the liver to the small intestine, where it is used to help digest food. When the bile ducts become inflamed, the bile cannot flow properly and can cause a buildup of bile in the liver and gallbladder. This can lead to an infection, or cholangitis. The most common symptom of cholangitis is severe abdominal pain, usually located in the upper right side of the abdomen. Other symptoms may include fever, chills, nausea, vomiting, jaundice, and dark urine.
Cholangitis is usually caused by an infection, such as a bacterial, viral, or fungal infection. It can also be caused by a blockage in the bile ducts, such as a gallstone or tumor. In some cases, cholangitis can be caused by an autoimmune disorder, such as primary sclerosing cholangitis.
The treatment for cholangitis depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed to treat the infection. If a blockage is the cause, it may need to be removed surgically. In some cases, medication may be prescribed to reduce inflammation and pain.
Cholecystitis is an inflammation of the gallbladder. The gallbladder is a small organ located in the upper right side of the abdomen that stores bile. When the gallbladder becomes inflamed, the bile cannot flow properly and can cause a buildup of bile in the liver and gallbladder. This can lead to an infection, or cholecystitis. The most common symptom of cholecystitis is severe abdominal pain, usually located in the upper right side of the abdomen. Other symptoms may include fever, chills, nausea, vomiting, jaundice, and dark urine.
Cholecystitis is usually caused by an infection, such as a bacterial, viral, or fungal infection. It can also be caused by a blockage in the gallbladder, such as a gallstone or tumor. In some cases, cholecystitis can be caused by an autoimmune disorder, such as primary sclerosing cholangitis.
The treatment for cholecystitis depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed to treat the infection. If a blockage is the cause, it may need to be removed surgically. In some cases, medication may be prescribed to reduce inflammation and pain.
The main difference between cholangitis and cholecystitis is the location of the inflammation. Cholangitis is an inflammation of the bile ducts, while cholecystitis is an inflammation of the gallbladder. Both conditions often cause similar symptoms, such as severe abdominal pain, fever, chills, nausea, vomiting, jaundice, and dark urine. However, the underlying causes and treatments for the two conditions may be different.
Cholangitis and cholecystitis are two of the most common biliary tract diseases and can cause severe pain and other symptoms.
1.
CD39 Blockade Shows Potential in Early-Stage Lung Cancer
2.
Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics
3.
PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.
4.
Venetoclax Combo Shows Promise in Younger Patients With AML
5.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics
3.
Hope in Numbers: Understanding AML Leukemia Survival Rates and Emerging Therapies
4.
Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights
5.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation